A5061654848- Medical Imaging Techniques and Applications
- Radiomics and Machine Learning in Medical Imaging
- Lymphoma Diagnosis and Treatment
- Cancer, Hypoxia, and Metabolism
- Breast Cancer Treatment Studies
- Lung Cancer Treatments and Mutations
- Sarcoma Diagnosis and Treatment
- Adrenal and Paraganglionic Tumors
- Breast Lesions and Carcinomas
- Neuroblastoma Research and Treatments
- CNS Lymphoma Diagnosis and Treatment
- Neurofibromatosis and Schwannoma Cases
- Cancer Diagnosis and Treatment
- MRI in cancer diagnosis
- Lung Cancer Diagnosis and Treatment
- Intraperitoneal and Appendiceal Malignancies
- Thyroid Cancer Diagnosis and Treatment
- Glioma Diagnosis and Treatment
- Head and Neck Cancer Studies
- Cancer and Skin Lesions
- Esophageal Cancer Research and Treatment
- Head and Neck Anomalies
- Gastrointestinal Tumor Research and Treatment
- Ovarian cancer diagnosis and treatment
- Endometrial and Cervical Cancer Treatments
Inje University Busan Paik Hospital
2011-2021
Busan Medical Center
2021
Inje University
2010-2015
Brigham and Women's Hospital
2014-2015
Harvard University
2014-2015
Kosin University Gospel Hospital
2007
Hanyang University
2005
Purpose Data in the literature regarding use of 18F-FDG avidity non–small cell lung cancer (NSCLC) as an imaging biomarker to predict status epidermal growth factor receptor (EGFR) mutation are conflicting. Association between KRAS and FDG NSCLC on PET/CT is not well known. We assessed whether EGFR or can be predicted by performing several different subgroup analyses better compare with various published results. Patients Methods After obtaining institutional review board approval, we...
A relatively new pathologic grading system, called residual cancer burden (RCB) criteria (0 to III), for assessing the response neoadjuvant chemotherapy (NCT) of breast has been reported be more accurate than conventional criteria. This study assesses value F-FDG PET/CT in early prediction chemotherapeutic determined based on these criteria.Thirty-six patients with locally advanced underwent before and after first (just second) cycle NCT. Percentage changes (%△) SUVmax, metabolic tumor...
This study evaluated the diagnostic efficacy of fluorine-18 fluorodeoxyglucose PET/CT (F-18 FDG PET/CT) for patients with gastric mucosa-associated lymphoid tissue (MALT) lymphoma and examined association between avidity clinical factors affecting lesions.Among diagnosed MALT lymphoma, 16 who underwent a were semi-quantitatively qualitatively tested lesions in stomach. Retrospectively collected data was analyzed to investigate clinicoradiological endoscopic findings positive F-18 scans those...
Background This study aimed to assess solid thyroid nodule (STN) cases with discordant sonographic and cytological diagnoses compare the diagnostic indices of these modalities. Methods From January 2013 December 2013, a single radiologist performed consecutive ultrasonography (US) US‐guided fine‐needle aspiration (US‐FNA) diagnose 347 STNs in patients. Each STN was classified into 1 5 categories according US diagnosis before US‐FNA: “benign,” “probably benign,” “indeterminate,” “suspicious...
In patients with advanced breast cancer, most new calcifications detected on a mammogram after neoadjuvant chemotherapy are benign dystrophic calcifications, but this is not always observed. We present patient cancer who had paradoxically increased malignant microcalcifications concomitant primary tumor regression undergoing chemotherapy. After the chemotherapy, follow-up revealed that local, fine pleomorphic markedly increased. Pathologically, these were ductal carcinoma in situ. concluded...
(123)I-Metaiodobenzylguanidine ((123)I-MIBG) scintigraphy is a widely used functional imaging tool with high degree of sensitivity and specificity in diagnosis pheochromocytoma. However, rare cases false positive reactions have been reported. A 67-year-old male patient was admitted epigastric pain. Abdominal computed tomography (CT) revealed heterogeneous left adrenal mass 6 cm diameter; following hormone testing, (123)I-MIBG performed to determine the presence pheochromocytoma, which...
To assess the prognostic value of preoperative 18 F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with high-risk stage II or III colon cancer who underwent FOLFOX chemotherapy.The study included 166 received FOLFOX4 chemotherapy. Retrospective patient data were analysed including pathological stage, histology, disease-free survival (DFS) and maximum standardized uptake (SUVmax ) primary tumour on tomography. The end point was DFS.There recurrences 29...
This study aimed to examine the diagnostic performance of F-18 fluorodeoxyglucose positron emission tomography with computed (F-18 FDG PET/CT) compared cancer antigen 125 (CA125), human epididymis protein 4 (HE4), and risk ovarian malignancy algorithm (ROMA) score distinguish epithelial from benign tumors.A total 46 patients pelvic masses, who underwent PET/CT, CA125, HE4 before surgery between January 2015 December 2018, were included in this retrospective study. The HE4, ROMA score,...
Purpose: We evaluated the accuracy of 18FFDG PET/CT for detection recurrence or metastasis after treatment in patients with primary head and neck cancer, compared results those CT/MRI. Materials Methods: studied 34 diagnosis who underwent follow up The were divided into two subgroups based on difference follow-up time interval type treatment. Accuracy was by information histopathology findings. CT/MRI statistical analysis. Results: For results, 19 FDG uptake lesions detected 17 patients....